Floatz logo

Carboplatin

Childhood Germ Cell Tumor

City of Hope Medical CenterSmall moleculePhase 3Dormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Childhood Germ Cell Tumor cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Masonic Cancer Center, University of Minnesota
Phase 2BBB
ETOPOSIDE
City of Hope Medical Center
Phase 3BB
Thiotepa
Masonic Cancer Center, University of Minnesota
Phase 2BB
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2BB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2BB

View all 21 →

Same molecule, other indications

Carboplatin is also rated in:

lung large cell carcinomaDormant
A
Indicative ·
80 / 100
View asset →
non-small cell squamous lung carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →